210 related articles for article (PubMed ID: 26592504)
21. Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.
Amant F; Steenkiste E; Schurmans K; Verbist L; Abeler VM; Tulunay G; de Jonge E; Massuger L; Moerman P; Vergote I
Int J Gynecol Cancer; 2004; 14(6):1118-21. PubMed ID: 15571618
[TBL] [Abstract][Full Text] [Related]
22. Significance of lymph node metastasis on survival of women with uterine adenosarcoma.
Machida H; Nathenson MJ; Takiuchi T; Adams CL; Garcia-Sayre J; Matsuo K
Gynecol Oncol; 2017 Mar; 144(3):524-530. PubMed ID: 28109626
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome and natural history of uterine adenosarcomas.
Arend R; Bagaria M; Lewin SN; Sun X; Deutsch I; Burke WM; Herzog TJ; Wright JD
Gynecol Oncol; 2010 Nov; 119(2):305-8. PubMed ID: 20688363
[TBL] [Abstract][Full Text] [Related]
24. Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.
Ashley CW; Da Cruz Paula A; Ferrando L; Gularte-Mérida R; Sebastiao APM; Brown DN; Gazzo AM; Pareja F; Stylianou A; Abu-Rustum NR; Reis-Filho JS; Buehler D; Weisman P; Chiang S; Weigelt B
Histopathology; 2021 Aug; 79(2):176-186. PubMed ID: 33527450
[TBL] [Abstract][Full Text] [Related]
25. Primary vaginal adenosarcoma with sarcomatous overgrowth.
Toyoshima M; Akahira J; Moriya T; Hayakawa S; Yaegashi N
Gynecol Oncol; 2004 Dec; 95(3):759-61. PubMed ID: 15582000
[TBL] [Abstract][Full Text] [Related]
26. Uterine adenosarcoma detected by Papanicolaou smear: a case report.
Pasternak S; MacIntosh R
Diagn Cytopathol; 2006 Jul; 34(7):495-8. PubMed ID: 16783778
[TBL] [Abstract][Full Text] [Related]
27. An unusual extrauterine variant of adenosarcoma with multiple recurrences over 16 years.
Benda JA; Veronezi-Gurwell A; Wilcox M; Buller R
Gynecol Oncol; 1994 Apr; 53(1):131-7. PubMed ID: 8175015
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine Adenosarcoma and Their Clinicopathological Significance.
Atilgan AO; Akcay EY; Ozen O; Haberal Reyhan AN; Ayhan A
Turk Patoloji Derg; 2023; 39(1):31-41. PubMed ID: 35876683
[TBL] [Abstract][Full Text] [Related]
29. ERBB-2 gene overexpression and amplification in uterine sarcomas.
Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
[TBL] [Abstract][Full Text] [Related]
30. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
Liu Y; Weber Z; San Lucas FA; Deshpande A; Jakubek YA; Sulaiman R; Fagerness M; Flier N; Sulaiman J; Davis CM; Fowler J; Starks D; Rojas-Espaillat L; Lazar AJ; Davies GE; Ehli EA; Scheet P
Gynecol Oncol; 2018 Nov; 151(2):243-249. PubMed ID: 30194005
[TBL] [Abstract][Full Text] [Related]
31. Uterine adenosarcomas overgrown by sex-cord-like tumour: report of two cases.
Stolnicu S; Balachandran K; Aleykutty MA; Loghin A; Preda O; Goez E; Nogales FF
J Clin Pathol; 2009 Oct; 62(10):942-4. PubMed ID: 19783725
[TBL] [Abstract][Full Text] [Related]
32. Pathology of mixed Müllerian tumours.
D'Angelo E; Prat J
Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):705-18. PubMed ID: 21742560
[TBL] [Abstract][Full Text] [Related]
33. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
34. Management of uterine adenosarcomas with and without sarcomatous overgrowth.
Tanner EJ; Toussaint T; Leitao MM; Hensley ML; Soslow RA; Gardner GJ; Jewell EL
Gynecol Oncol; 2013 Apr; 129(1):140-4. PubMed ID: 23283300
[TBL] [Abstract][Full Text] [Related]
35. Primary Fallopian Tube Mullerian Adenosarcoma With Sarcomatous Overgrowth and a Previously Unreported MEIS1-NCOA2 Gene Fusion.
Ribeiro E Ribeiro R; Lewin ER; Hart JL; Quddus MR; Hansen K
Int J Gynecol Pathol; 2022 Jan; 41(1):82-85. PubMed ID: 33770059
[TBL] [Abstract][Full Text] [Related]
36. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
37. [Uterine adenosarcoma. Apropos of a case of uterine and vaginal adenosarcoma with a corrected genital prolapse].
Kabwa L; Mattei JP; Eloit S; Ramadane A; Grange B
J Chir (Paris); 1997 Jul; 134(2):80-5. PubMed ID: 9378790
[TBL] [Abstract][Full Text] [Related]
38. Juvenile granulosa cell tumor arising in ovarian adenosarcoma: an unusual form of sarcomatous overgrowth.
Carleton C; Houghton OP; McCluggage WG
Hum Pathol; 2015 Apr; 46(4):614-9. PubMed ID: 25656930
[TBL] [Abstract][Full Text] [Related]
39. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
[TBL] [Abstract][Full Text] [Related]
40. Uterine adenosarcoma with ovarian sex cord-like differentiation: a case report and review of the literature.
Ulker V; Yavuz E; Gedikbasi A; Numanoglu C; Sudolmus S; Gulkilik A
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):518-21. PubMed ID: 22212329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
